🔗 Share this article

An underground market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the platform has removed problematic content and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Digital Trading Operations

Research also found groups with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.

Within moments of entering one group, a vendor shared contact information, where most transactions take place. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, posts show dark colored packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has already seen patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject users to possibly serious medical dangers”.